Recombinant candida utilis uricase (Beijing SL Pharmaceutical)

重组假丝酵母尿酸氧化酶（北京双鹭药业）

Report date: 2022/04/08 14:36:00

Base Information

Drug NameRecombinant candida utilis uricase (Beijing SL Pharmaceutical)
Drug Alias Namerecombinant uricase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUrate oxidases replacements
TargetsUrate oxidase
Therapy Area/IndicationsHyperuricemiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperuricemiaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A